Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy

Molecularly Imprinted Polymers (MIPs) as Theranostic Systems for Sunitinib Controlled Release and Self-Monitoring in Cancer Therapy

Cytotoxic agents that are used conventionally in cancer therapy present limitations that affect their efficacy and safety profile, leading to serious adverse effects. In the aim to overcome these drawbacks, different approaches have been investigated and, among them, theranostics is attracting inter...

Full description

Bibliographic Details
Main Authors: Ortensia Ilaria Parisi, Mariarosa Ruffo, Rocco Malivindi, Anna Francesca Vattimo, Vincenzo Pezzi, Francesco Puoci
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Pharmaceutics
Subjects:
molecularly imprinted polymers (mips)
molecular imprinting
theranostics
sunitinib
cancer therapy
controlled release
drug delivery systems (ddss)
adsorption and release kinetics
precipitation polymerization
Online Access:https://www.mdpi.com/1999-4923/12/1/41

Internet

https://www.mdpi.com/1999-4923/12/1/41

Similar Items